• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEICA BIOSYSTEMS MELBOURNE PTY. LTD PELORIS TISSUE PROCESSOR; AUTOMATED TISSUE PROCESSOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEICA BIOSYSTEMS MELBOURNE PTY. LTD PELORIS TISSUE PROCESSOR; AUTOMATED TISSUE PROCESSOR Back to Search Results
Model Number PELORIS II
Device Problem Application Program Problem: Parameter Calculation Error (1449)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/11/2019
Event Type  malfunction  
Manufacturer Narrative
Based on the information provided, the tissue samples exhibiting sub-optimal tissue processing are derived from the "e.12 hour - large" protocol comprising 131 cassettes, which started in retort b at 22:58pm on 08 march 2019 and failed at 06:26am on 11 march 2019 during step 10, which is the third clearing step of the protocol; and the "e.12 hour - large" protocol comprising 283 cassettes, which started in retort a at 23:05pm on 08 march 2019 and completed at 06:26am on 11 march 2019.Investigation of this complaint found that processing of tissue samples in both the affected protocols was delayed because the condensate bottle was not in contact with the corresponding sensor, which resulted in pausing of both protocols for approximately nine (9) hours and 50 minutes between 20:21pm on 10 march 2019 and 05:51am on 11 march 2019, until a user reinserted the condensate bottle.Steps 2 to 10 of the "e.12 hour - large" protocol started in retort b at 22:58pm on 08 march 2019 were executed between 05:51am and 06:26am on 11 march 2016 at a reduced duration in an attempt to meet the end time calculated by the software scheduler.The reduced duration of these processing steps did not allow sufficient time to adequately heat the retort manifold for wax transfer resulting in failure of at the first wax infiltration step.Steps 6 to 13 of the "e.12 hour - large" protocol started in retort a at 23:05pm on 08 march 2019 were also executed between 05:51am and 06:26am on 11 march 2016 at a reduced duration in an attempt to meet the end time calculated by the software scheduler.The root cause of the condensate bottle moving out of contact with the corresponding sensor cannot be unequivocally determined from the information available.The root cause of the sub-optimal tissue processing reported by the complainant from the "e.12 hour - large" protocol started in retort b at 22:58pm on 08 march 2019 was insufficient dehydration and clearing of the tissue samples involved as a consequence of the eight (8) processing steps completed being executed in 34 minutes in an attempt to meet the end time calculated by the software scheduler.The root cause of the sub-optimal tissue processing reported by the complainant from the "e.12 hour - large" protocol started in retort a at 23:05pm on 08 march 2019 was insufficient dehydration, clearing and wax infiltration of the tissue samples involved as a consequence of the seven (7) processing steps completed being executed in 34 minutes in an attempt to meet the end time calculated by the software scheduler.
 
Event Description
Leica biosystems received a complaint that "tissue was not hydrated and wax will not stick to it and sections cannot be cut" following processing.The complainant reported that no error codes had been displayed for retort a; event code "1001" had been recorded for retort b; the condensate bottle was not pushed into the instrument far enough; all reagents were correct and the alcohols were the correct percentage.On 21 march 2019, leica biosystems melbourne received the following information from the leica senior field service technician (fse): ".All tissues were diagnosed.Since it had to be reprocessed, the processing quality wasn't good".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PELORIS TISSUE PROCESSOR
Type of Device
AUTOMATED TISSUE PROCESSOR
Manufacturer (Section D)
LEICA BIOSYSTEMS MELBOURNE PTY. LTD
495 blackburn road
mount waverley, vic 3149
AS  3149
Manufacturer (Section G)
LEICA BIOSYSTEMS MELBOURNE PTY. LTD
495 blackburn road
mount waverley, vic 3149
AS   3149
Manufacturer Contact
adrienne hardisty
495 blackburn road
mount waverley, vic 3149
AS   3149
MDR Report Key8481394
MDR Text Key148628328
Report Number8020030-2019-00011
Device Sequence Number1
Product Code IEO
Combination Product (y/n)N
Reporter Country CodeCA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 04/04/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/04/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model NumberPELORIS II
Device Catalogue Number26.0008
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/11/2019
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/12/2013
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-